Editas Medicine (EDIT) Q4 2023 Earnings Report

3,589 Followers

EDIT Q4 2023 EPS Results

Actual EPS-$0.23

Consensus EPS-$0.59

Beat/MissBeat by +$0.36

One Year Ago EPS-$0.88

Actual Revenue$60.05M

Expected Revenue$3.70M

Beat/MissBeat by +$56.35M

YoY Revenue Growth+818.74%

QuarterQ4 2023

Date02/28/2024

TimeBefore Open

Conference CallWednesday, February 28, 2024

EDIT Upcoming Earnings

Editas Medicine's next earnings date is estimated for November 9, 2026, based on past reporting schedules.

EDIT Q4 2023 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 09, 2026	2026 (Q3)	-0.19 / -	-0.28	―
Aug 05, 2026	2026 (Q2)	-0.27 / -0.15	-0.63	76.19% (+0.48)
May 05, 2026	2026 (Q1)	-0.26 / -0.26	-0.92	71.74% (+0.66)
Mar 09, 2026	2025 (Q4)	-0.23 / -0.06	-0.55	89.09% (+0.49)
Nov 10, 2025	2025 (Q3)	-0.30 / -0.28	-0.75	62.67% (+0.47)
Aug 12, 2025	2025 (Q2)	-0.39 / -0.63	-0.82	23.17% (+0.19)
May 12, 2025	2025 (Q1)	-0.56 / -0.92	-0.76	-21.05% (-0.16)
Mar 05, 2025	2024 (Q4)	-0.38 / -0.55	-0.23	-139.13% (-0.32)
Nov 04, 2024	2024 (Q3)	-0.75 / -0.75	-0.55	-36.36% (-0.20)
Aug 07, 2024	2024 (Q2)	-0.70 / -0.82	-0.56	-46.43% (-0.26)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed